Position in XERS
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$34,730,315
+$17,814,047 QoQ
Shares Held
4,385,141
+50.4% QoQ
Ownership
2.41%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#6
of 238 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in XERS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Nuveen, LLC holds $1,256,235,792 across 44 Drug Manufacturers - Specialty & Generic names. XERS ranks #13 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HLN |
Haleon plc
|
15,332,859 | $143,055,573 | |
| 2 | ZTS |
Zoetis Inc.
|
1,799,647 | $129,322,632 | |
| 3 | ALKS |
Alkermes plc.
|
2,324,197 | $121,787,920 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
3,230,980 | $109,465,602 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
200,059 | $108,397,967 | |
| 6 | VTRS |
Viatris Inc
|
6,007,467 | $95,398,575 | |
| 7 | NBIX |
Neurocrine Biosciences Inc
|
459,301 | $77,410,589 | |
| 8 | AMRX |
Amneal Pharmaceuticals, Inc.
|
3,324,875 | $57,553,584 |
All Filings in XERS
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $34,730,315 | 4,385,141 | Shares | Defined | 2026-08-11 | |
| 2026-03-31 | $16,916,268 | 2,916,598 | Shares | Defined | 2026-04-30 | |
| 2025-12-31 | $22,033,425 | 2,806,806 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $23,018,892 | 2,827,874 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $12,144,063 | 2,600,442 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $12,239,991 | 2,229,507 | Shares | Defined | 2025-05-12 | |
| No filing history on record for this holder in this stock. | ||||||